IL10 and acute myeloid leukemia: Moreover, in the presence of this engineered IL-10 variant, chimeric antigen receptor (CAR) T cells expanded and exhibited significantly greater cytotoxicity against acute myeloid leukemia cells compared to those cultured with wild-type IL-10 [68].